Funding Opportunity
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Deadline:
Solication URL:http://grants.nih.gov/grants/guide/pa-files/PAR-25-101.html
Post Date:December 30, 2024
Close Date:August 11, 2027
Last Updated Date:March 31, 2025
Opportunity ID: 357941
Opportunity Number: PAR-25-101
Agency Name: National Institutes of Health
Eligible Applicants:
0 - State governments1 - County governments
2 - City or township governments
4 - Special district goverments
5 - Independent school districts
6 - Public and State controlled institutions of higher education
7 - Native American tribal governments (Federally recognized)
8 - Public housing authorities/Indian housing authorities
11 - Native American tribal organizations (other than Federally recognized tribal governments)
12 - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education
13 - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education
20 - Private institutions of higher education
22 - For-profit organizations other than small businesses
23 - Small businesses
25 - Others
